Actively Recruiting
Extracorporeal Shock Wave Therapy on Spastic Equinus Foot in Stroke Patients
Led by Teresa Mateu Campos · Updated on 2024-09-19
60
Participants Needed
1
Research Sites
270 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is to evaluate long term effects of focused extracorporeal shock wave therapy (fESWT) on triceps surae spasticity in stroke patients according to the number of sessions applied. Hypothesis: 3 sessions of fESWT on equinus foot in stroke patients improve spasticity and functionality for longer term than 1 session of fESWT.
CONDITIONS
Official Title
Extracorporeal Shock Wave Therapy on Spastic Equinus Foot in Stroke Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age greater than 18 years old
- Time from stroke (ischemic or hemorrhagic) onset of at least 6 months
- Spastic equinus foot with triceps surae tone grade at least 1+ on the Modified Ashworth Scale
- Ability to walk alone with or without aids
You will not qualify if you...
- Fixed ankle joint contracture
- Severe medical problems
- Treatment of the affected leg with botulinum toxin in the last 6 months
- Cognitive impairment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital de la Plana
Vila-real, Castellon, Spain, 12540
Actively Recruiting
Research Team
T
Teresa Mª Mateu Campos
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here